netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

Stem Cells Regenerate Human Lens After Cataract Surgery In Children

In a breakthrough that could have broader implications for human tissue and organ regeneration, RPB-supported scientists report that, by leaving local stem cells intact during surgery to remove the lens in infants who develop congenital cataracts, a functional lens can be regrown.

The researchers are now looking to expand their work to treating age-related cataracts. The potential resulting paradigm shift in cataract surgery would be especially timely, since the world's aging population has been predicted to double the need for cataract surgeries over the next 20 years. 

Read the story.


Read the study.

More on Cataract

Related News: Cataract, Pediatric , Stem Cell Therapy, Top Story

test tubes

The Time is Now to Protect the National Eye Institute

The existence of the National Eye Institute, the most important source of funding for vision research in the U.S., is being threatened.

Read More

 
eye brain connection

RPB Grantees Contribute to Eye Transplantation Effort

The ARPA-H THEA project takes on an exciting challenge.

Read More

 
microscope

Faulty Vision for US Eye Research

An important message from an RPB Trustee

Read More

 
Giving Tuesday logo

Giving the Gift of Sight

#GivingTuesday kicks off with a donation match

Read More

 
eye photo

New Grants for Big Data Research to Improve Vision Care

Read More

 
RPB Logo

Research to Prevent Blindness Opens Applications for Vision Research Grants

The awards offered cover a wide variety of topics in vision science, including glaucoma, age-related macular degeneration, retinal diseases, and many more.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.